Development and validation of an lc-ms/ms method for determination of tigecycline and its epimer in human plasma and its application in a pharmacokinetic study

5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A rapid, selective, sensitive, and simple method for simultaneous determination of tigecycline and its epimer in human plasma samples was developed and validated by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Sample preparation involved one-step protein precipitation by adding 0.1% formic acid-methanol and phosphate buffer (PB) solution to the plasma. Chromatographic separation was obtained with XBridge BEH C18 column (3.5 ?m, 50 × 4.6 mm) through a 9.5-min gradient mobile phase at the flow rate of 0.6 mL min-1 at 4 °C. The calibration curves were linear over concentration 5.00-2000 ng mL-1 with correlation coefficient greater than 0.998. Intra-batch and inter-batch accuracy of the assay were in the ranges of -2.90% to 3.00%, and the corresponding precision was less than 6.97%. The extraction recovery of tigecycline and its epimer with the current method were 87.2% and 76.9%, respectively. The applied LC-MS/MS method was shown to be sufficiently sensitive and will be suitable for pharmacokinetic studies.

Author supplied keywords

Cite

CITATION STYLE

APA

Wang, L., Hu, X., Zhu, H., Zhang, X., Wang, C., & Han, Z. (2016). Development and validation of an lc-ms/ms method for determination of tigecycline and its epimer in human plasma and its application in a pharmacokinetic study. Acta Chromatographica, 28(2), 239–253. https://doi.org/10.1556/1326.2016.28.4.2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free